10 Best Diabetes Stocks To Buy Under $10

1. Senseonics Holdings, Inc. (NYSE:SENS)

Share Price as of the Close of December 26: $0.58

Senseonics Holdings, Inc. (NYSE:SENS) tops the list for being one of the best diabetes stocks. It develops implantable continuous glucose monitoring (CGM) systems for diabetes management. Its flagship products, including Eversense, Eversense XL, and Eversense 365, feature a sensor implanted under the skin, a rechargeable transmitter, and a mobile app for real-time glucose tracking. The Eversense 365 stands out as the world’s first year-long CGM system.

In Q3 2024, Senseonics Holdings, Inc. (NYSE:SENS) achieved key milestones, including FDA approval and the launch of the Eversense 365, a 365-day CGM system, with Ascensia Diabetes Care leading commercialization and Mercy Health System performing the first patient insertion. Revenue was $4.3 million, down from $6.1 million in Q3 2023, due to inventory transitions to Eversense 365.

Senseonics Holdings, Inc. (NYSE:SENS) reported a $4.1 million gross loss from $4.8 million in one-time transition charges, while operating expenses rose to $8.3 million, and R&D expenses decreased to $10.5 million. Net loss remained at $24.0 million ($0.04 per share), similar to Q3 2023, bolstered by $20 million in equity offerings and a post-quarter $16 million financing, bringing its cash position to $74.8 million with $55.9 million in debt.

Senseonics Holdings, Inc. (NYSE:SENS) has seen promising results following the Eversense 365 launch, including doubling Direct-to-Consumer leads in October and November, achieving record new patient shipments, and a 42% increase in prescribing providers. Prescriptions from top prescribers rose by 69%, with one-third being first-time users. The company plans to double U.S. patient starts and grow its global base by 50% in 2024, focusing on product development, pump connectivity, healthcare partnerships, and the international launch of Eversense 365. A reverse stock split is planned for January 2025 to attract institutional investors.

Overall, Senseonics Holdings, Inc. (NYSE:SENS) ranks first among the 10 best diabetes stocks to buy under $10. While we acknowledge the potential of healthcare companies, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is more promising than SENS but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.